Sun Pharma Executive and Leadership Team

Lisa Khan, the Chief Executive Officer at Sun Pharma, directs the overarching corporate strategy and operational execution for the global pharmaceutical enterprise. Overseeing all business units, Khan ensures alignment with the company's mission to provide high-quality specialty generics. This leadership position involves driving market expansion and optimizing resource allocation across diverse product lines. By fostering cross-functional collaboration, Lisa Khan enhances the company's ability to bring innovative treatments to market. The Chief Executive Officer's focus remains on sustainable growth and strengthening Sun Pharma's position as a leader in the pharmaceutical industry. Khan's strategic direction guides the development of new formulations and the efficient distribution of active pharmaceutical ingredients worldwide.

Carolyn Bessette, the Principal Chief Executive Officer at Sun Pharma, spearheads the strategic vision and long-term planning for the organization. Bessette's role encompasses guiding the company's expansion into new therapeutic areas and enhancing its global market presence. This executive function involves critical decision-making regarding research and development investments and strategic partnerships. By championing a culture of excellence, Carolyn Bessette ensures the highest standards in pharmaceutical manufacturing and distribution. The Principal Chief Executive Officer's leadership is pivotal in navigating complex regulatory landscapes and driving operational efficiencies. Bessette's commitment to innovation underpins Sun Pharma's objective of delivering accessible and effective healthcare solutions.

Kal Sundaram, the Chief Executive Officer, America' at Sun Pharma, directs the strategic growth and operational management of the company's business across the Americas region. Sundaram's leadership focuses on expanding Sun Pharma's market footprint and optimizing its product offerings to meet regional healthcare demands. This executive role involves overseeing sales, marketing, and distribution networks throughout North and South America. By fostering strong relationships with healthcare providers and stakeholders, Kal Sundaram drives market penetration and revenue generation. The Chief Executive Officer, America''s strategic initiatives are essential for solidifying Sun Pharma's presence and competitive advantage in these vital markets. Sundaram's vision guides the region's contribution to the company's global success.

Jayashree Satagopan, the Global Chief Financial Officer at Sun Pharma, oversees the company's worldwide financial operations and strategic fiscal planning. Satagopan's responsibilities include managing financial reporting, budgeting, and capital allocation to support global growth initiatives. This critical role involves ensuring financial stability and driving profitability across all international markets. By providing insightful financial analysis, Jayashree Satagopan guides executive decision-making and resource deployment. The Global Chief Financial Officer's expertise is fundamental to Sun Pharma's sustained economic performance and its ability to invest in research and development. Satagopan's strategic financial management strengthens the company's long-term viability and shareholder value.

Akshay Sethi, the Group Chief Financial Officer at Sun Pharma, manages the financial health and strategic fiscal direction of the company's consolidated business units. Sethi's role involves overseeing financial planning, risk management, and ensuring compliance with global accounting standards across the group. This position is essential for maintaining financial transparency and driving operational efficiency throughout the organization. By providing critical financial insights, Akshay Sethi supports informed strategic decision-making at the executive level. The Group Chief Financial Officer's stewardship ensures robust financial controls and optimizes capital deployment for growth. Sethi's financial acumen is key to Sun Pharma's sustained profitability and market leadership.

Zvi Albert, the Chief Financial Officer (North America) at Sun Pharma, directs the financial strategy and operations for the company within the North American market. Albert's responsibilities include financial planning, analysis, and reporting specific to the region, ensuring alignment with global financial objectives. This role is critical for managing regional profitability and optimizing financial performance across North American business activities. By overseeing fiscal operations, Zvi Albert supports strategic investments and drives efficient resource allocation. The Chief Financial Officer (North America)'s financial expertise is instrumental in navigating the unique economic landscape of the region. Albert's leadership ensures Sun Pharma's financial strength and growth in this key market.

Jaydeep Shah, the Chief Marketing Officer, Consumer Health Business, Sun Pharma at Sun Pharma, drives the strategic marketing initiatives for the company's consumer health portfolio. Shah's responsibilities include developing and executing comprehensive marketing plans to increase brand visibility and market share within the consumer segment. This role involves deep market analysis to identify emerging consumer needs and trends. By leading the consumer health marketing team, Jaydeep Shah ensures the effective promotion of products across various channels. The Chief Marketing Officer, Consumer Health Business, Sun Pharma's efforts are crucial for building strong consumer relationships and driving revenue growth in this key business area. Shah's strategic approach enhances Sun Pharma's brand equity in the consumer health market.

Darshita Shah, the Quality Assurance Specialist & Chief Marketing Officer I ( Compliance) at Sun Pharma, ensures rigorous adherence to quality standards and regulatory compliance across all operations. Shah's dual role involves overseeing the implementation of robust quality assurance protocols and managing compliance-related marketing strategies. This position is critical for maintaining the integrity and safety of Sun Pharma's pharmaceutical products. By championing a culture of compliance, Darshita Shah safeguards the company's reputation and market access. The Quality Assurance Specialist & Chief Marketing Officer I ( Compliance)'s expertise is vital in navigating complex global regulatory frameworks. Shah's meticulous attention to detail supports Sun Pharma's commitment to delivering safe and effective medicines.

Suresh Rai, the Global Chief Human Resources Officer at Sun Pharma, leads the company's human capital strategy and organizational development initiatives on a worldwide scale. Rai's purview includes talent acquisition, employee engagement, and fostering a positive corporate culture that supports Sun Pharma's mission. This executive function is vital for attracting and retaining top talent across diverse global operations. By implementing progressive HR policies, Suresh Rai ensures a motivated and high-performing workforce. The Global Chief Human Resources Officer's strategic focus on people development is integral to Sun Pharma's operational excellence and innovation pipeline. Rai's leadership cultivates an environment where employees can thrive and contribute to the company's success.

Faried Niamut, the Manager, Quality Assurance & Chief Marketing Officer, Biologics & Pharma Branded at Sun Pharma, oversees critical quality assurance functions and spearheads marketing strategies for the biologics and branded pharmaceutical segments. Niamut's dual focus ensures that product quality meets stringent regulatory requirements while driving market adoption and brand recognition. This role involves developing targeted marketing campaigns that highlight the unique value propositions of Sun Pharma's biologics and branded offerings. By integrating quality assurance with marketing leadership, Faried Niamut enhances product integrity and market competitiveness. The Manager, Quality Assurance & Chief Marketing Officer, Biologics & Pharma Branded's strategic vision supports the growth of these specialized business areas. Niamut's efforts are vital for Sun Pharma's success in these high-value therapeutic categories.